186 related articles for article (PubMed ID: 30816220)
1. Efficacy of aldose reductase inhibitors is affected by oxidative stress induced under X-ray irradiation.
Castellví A; Crespo I; Crosas E; Cámara-Artigas A; Gavira JA; Aranda MAG; Parés X; Farrés J; Juanhuix J
Sci Rep; 2019 Feb; 9(1):3177. PubMed ID: 30816220
[TBL] [Abstract][Full Text] [Related]
2. The role of Cys-298 in aldose reductase function.
Balendiran GK; Sawaya MR; Schwarz FP; Ponniah G; Cuckovich R; Verma M; Cascio D
J Biol Chem; 2011 Feb; 286(8):6336-44. PubMed ID: 21084309
[TBL] [Abstract][Full Text] [Related]
3. Synthesis and evaluation of novel aldose reductase inhibitors: Effects on lens protein kinase Cgamma.
Lewis S; Karrer J; Saleh S; Chan X; Tan Z; Hua D; McGill J; Pang YP; Fenwick B; Brightman A; Takemoto D
Mol Vis; 2001 Jul; 7():164-71. PubMed ID: 11483892
[TBL] [Abstract][Full Text] [Related]
4. Mechanism of human aldehyde reductase: characterization of the active site pocket.
Barski OA; Gabbay KH; Grimshaw CE; Bohren KM
Biochemistry; 1995 Sep; 34(35):11264-75. PubMed ID: 7669785
[TBL] [Abstract][Full Text] [Related]
5. Redox state-dependent and sorbitol accumulation-independent diabetic albuminuria in mice with transgene-derived human aldose reductase and sorbitol dehydrogenase deficiency.
Ii S; Ohta M; Kudo E; Yamaoka T; Tachikawa T; Moritani M; Itakura M; Yoshimoto K
Diabetologia; 2004 Mar; 47(3):541-548. PubMed ID: 14968292
[TBL] [Abstract][Full Text] [Related]
6. Modulation of activity and inhibitor sensitivity of rabbit aldose reductase-like protein (AKR1B19) by oxidized glutathione and SH-reagents.
Endo S; Fujimoto A; Kumada S; Matsunaga T; Ohno S; Mano J; Tajima K; El-Kabbani O; Hara A
Chem Biol Interact; 2013 Feb; 202(1-3):146-52. PubMed ID: 23261715
[TBL] [Abstract][Full Text] [Related]
7. Human aldose reductase unfolds through an intermediate.
Sekhon G; Singh R
F1000Res; 2019; 8():564. PubMed ID: 31723418
[No Abstract] [Full Text] [Related]
8. Acute onset of diabetic pathological changes in transgenic mice with human aldose reductase cDNA.
Yamaoka T; Nishimura C; Yamashita K; Itakura M; Yamada T; Fujimoto J; Kokai Y
Diabetologia; 1995 Mar; 38(3):255-61. PubMed ID: 7758869
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of C298S mutant of human aldose reductase for antidiabetic applications: Evidence from in silico elementary mode analysis of biological network model.
Khan S; Bhardwaj T; Somvanshi P; Mandal RK; Dar SA; Jawed A; Wahid M; Akhter N; Lohani M; Alouffi S; Haque S
J Cell Biochem; 2018 Aug; 119(8):6961-6973. PubMed ID: 29693278
[TBL] [Abstract][Full Text] [Related]
10. Inhibitory activities of selected Kampo formulations on human aldose reductase.
Onoda T; Ishikawa C; Fukazawa T; Li W; Obayashi M; Koike K
BMC Complement Altern Med; 2014 Nov; 14():435. PubMed ID: 25374323
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, structure-activity relationships and X-ray structural studies of novel 1-oxopyrimido[4,5-c]quinoline-2-acetic acid derivatives as selective and potent inhibitors of human aldose reductase.
Crespo I; Giménez-Dejoz J; Porté S; Cousido-Siah A; Mitschler A; Podjarny A; Pratsinis H; Kletsas D; Parés X; Ruiz FX; Metwally K; Farrés J
Eur J Med Chem; 2018 May; 152():160-174. PubMed ID: 29705708
[TBL] [Abstract][Full Text] [Related]
12. Oxidized aldose reductase: in vivo factor not in vitro artifact.
Grimshaw CE; Lai CJ
Arch Biochem Biophys; 1996 Mar; 327(1):89-97. PubMed ID: 8615700
[TBL] [Abstract][Full Text] [Related]
13. Normalization of lens protein kinase Cgamma in galactosemic dogs by a novel aldose reductase inhibitor.
Takemoto DJ; Harris R; Brightman A; McGill J; Hua D; Davidson H; Fenwick B; Wagner LM
Vet Ophthalmol; 2004; 7(3):163-7. PubMed ID: 15091323
[TBL] [Abstract][Full Text] [Related]
14. Aldose reductase inhibitors and nanodelivery of diabetic therapeutics.
Prior AM; Thapa M; Hua DH
Mini Rev Med Chem; 2012 Apr; 12(4):326-36. PubMed ID: 22303947
[TBL] [Abstract][Full Text] [Related]
15. Acid Derivatives of Pyrazolo[1,5-a]pyrimidine as Aldose Reductase Differential Inhibitors.
Balestri F; Quattrini L; Coviello V; Sartini S; Da Settimo F; Cappiello M; Moschini R; Del Corso A; Mura U; La Motta C
Cell Chem Biol; 2018 Nov; 25(11):1414-1418.e3. PubMed ID: 30122369
[TBL] [Abstract][Full Text] [Related]
16. Human Aldose Reductase Expression Prevents Atherosclerosis Regression in Diabetic Mice.
Yuan C; Hu J; Parathath S; Grauer L; Cassella CB; Bagdasarov S; Goldberg IJ; Ramasamy R; Fisher EA
Diabetes; 2018 Sep; 67(9):1880-1891. PubMed ID: 29891593
[TBL] [Abstract][Full Text] [Related]
17. Recent studies of aldose reductase enzyme inhibition for diabetic complications.
Suzen S; Buyukbingol E
Curr Med Chem; 2003 Aug; 10(15):1329-52. PubMed ID: 12871133
[TBL] [Abstract][Full Text] [Related]
18. Structural and functional properties of aldose xylose reductase from the D-xylose-metabolizing yeast Candida tenuis.
Nidetzky B; Mayr P; Neuhauser W; Puchberger M
Chem Biol Interact; 2001 Jan; 130-132(1-3):583-95. PubMed ID: 11306077
[TBL] [Abstract][Full Text] [Related]
19. Residues affecting the catalysis and inhibition of rat lens aldose reductase.
Carper DA; Hohman TC; Old SE
Biochim Biophys Acta; 1995 Jan; 1246(1):67-73. PubMed ID: 7811733
[TBL] [Abstract][Full Text] [Related]
20. Active site modification of aldose reductase by nitric oxide donors.
Chandra A; Srivastava S; Petrash JM; Bhatnagar A; Srivastava SK
Biochim Biophys Acta; 1997 Sep; 1341(2):217-22. PubMed ID: 9357961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
